Breaking News Instant updates and real-time market news.

ENDP

Endo

$12.12

-0.06 (-0.49%)

12:35
08/06/18
08/06
12:35
08/06/18
12:35

Endo put volume heavy and directionally bearish

Bearish flow noted in Endo with 3,512 puts trading, or 8x expected. Most active are Oct-18 12 puts and Aug-18 12 puts, with total volume in those strikes near 2,900 contracts. The Put/Call Ratio is 6.60, while ATM IV is up nearly 5 points on the day. Earnings are expected on August 8th.

  • 08

    Aug

  • 04

    Sep

ENDP Endo
$12.12

-0.06 (-0.49%)

07/18/18
DBAB
07/18/18
NO CHANGE
Target $11
DBAB
Buy
Deutsche ups Endo target to $11 after management meetings
Deutsche Bank analyst Gregg Gilbert raised his price target for Endo International to $11 from $10 after hosting investor meetings with management. The analyst sees the potential for "continued good" share performance if management continues to deliver on its plan. He cites higher Vasostrict sales assumptions following the recent price increase for his target boost and keeps a Buy rating on Endo. There could be upside to the company's outlook if additional generic competition to some important products does not materialize, Gilbert tells investors in a research note.
07/11/18
SBSH
07/11/18
NO CHANGE
SBSH
Endo risk/reward remains favorable, says Citi
After hosting management on a roadshow, Citi analyst Liav Abraham says the risk/reward on shares of Endo International remains favorable. The analyst views the current valuation as "undemanding" and believes "solid execution" of the base business creates upside to Street estimates. She keeps a Buy rating on Endo shares.
06/29/18
RILY
06/29/18
NO CHANGE
Target $13
RILY
Buy
Endo price target raised to $13 from $10 at B. Riley FBR
B. Riley FBR analyst David Buck raised his price target for Endo International to $13 saying he remains positive on the shares amidst the company's turnaround. The analyst keeps a Buy rating on the name.
06/27/18
SBSH
06/27/18
UPGRADE
SBSH
Buy
Endo upgraded to Buy from Neutral at Citi
Citi analyst Liav Abraham upgraded Endo International to Buy from Hold, telling investors in a research note that he is moving off the sidelines. Abraham says he sees a "favorable" risk-reward profile at current levels, even after the recent upward inflection in the share price. He sees potential for an inflection in revenues in 2019 given continued execution on the base business, as well as the contribution of the Somerset acquisition.

TODAY'S FREE FLY STORIES

EBS

Emergent BioSolutions

$49.51

-0.43 (-0.86%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Hot Stocks
Emergent BioSolutions begins Phase 3 trial to evaluate AV7909 »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRE

CareTrust REIT

$23.38

-0.49 (-2.05%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Hot Stocks
CareTrust REIT increases quarterly dividend 9.8% to 22.5c per share »

CareTrust REIT announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

$0.00

(0.00%)

, AAPL

Apple

$188.03

1.83 (0.98%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Periodicals
Foxconn aims to finish Wisconsin LCD plant by end of 2020, Reuters says »

Foxconn (HNHPF) has…

HNHPF

Hon Hai Precision

$0.00

(0.00%)

AAPL

Apple

$188.03

1.83 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$37.99

-0.095 (-0.25%)

, LYFT

Lyft

$0.00

(0.00%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Periodicals
General Motors mulls options for Lyft stake after IPO, Reuters reports »

General Motors' (GM)…

GM

General Motors

$37.99

-0.095 (-0.25%)

LYFT

Lyft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 30

    Apr

  • 29

    Mar

IMGN

ImmunoGen

$2.59

-0.07 (-2.63%)

, JAZZ

Jazz Pharmaceuticals

$134.45

-2.29 (-1.67%)

06:30
03/19/19
03/19
06:30
03/19/19
06:30
Downgrade
ImmunoGen, Jazz Pharmaceuticals rating change  »

JPMorgan downgrades…

IMGN

ImmunoGen

$2.59

-0.07 (-2.63%)

JAZZ

Jazz Pharmaceuticals

$134.45

-2.29 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

SBUX

Starbucks

$70.84

0.17 (0.24%)

06:27
03/19/19
03/19
06:27
03/19/19
06:27
Hot Stocks
Starbucks announces enhancements to Starbucks Rewards loyalty program »

Starbucks announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

DPZ

Domino's Pizza

$243.35

-0.895 (-0.37%)

, YUM

Yum! Brands

$100.25

-0.62 (-0.61%)

06:25
03/19/19
03/19
06:25
03/19/19
06:25
Recommendations
Domino's Pizza, Yum! Brands analyst commentary  »

JPMorgan upgrades…

DPZ

Domino's Pizza

$243.35

-0.895 (-0.37%)

YUM

Yum! Brands

$100.25

-0.62 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 01

    May

BCOR

Blucora

$28.33

-0.02 (-0.07%)

06:24
03/19/19
03/19
06:24
03/19/19
06:24
Earnings
Blucora raises Q1 EPS view to $1.41-$1.49 from $1.19-$1.26, consensus $1.25 »

Raises Q1 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$35.15

0.32 (0.92%)

06:22
03/19/19
03/19
06:22
03/19/19
06:22
Conference/Events
Avis Budget management to meet with Northcoast »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

FIS

FIS

$108.14

-0.73 (-0.67%)

06:22
03/19/19
03/19
06:22
03/19/19
06:22
Downgrade
FIS rating change  »

FIS downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

BLD

TopBuild

$63.98

0.17 (0.27%)

06:22
03/19/19
03/19
06:22
03/19/19
06:22
Downgrade
TopBuild rating change  »

TopBuild downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

F

Ford

$8.57

0.14 (1.66%)

06:21
03/19/19
03/19
06:21
03/19/19
06:21
Periodicals
Ford to increase production rate for U.S. large SUVs, Reuters reports »

Ford's Kentucky…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

ARQL

ArQule

$4.79

0.095 (2.03%)

06:20
03/19/19
03/19
06:20
03/19/19
06:20
Conference/Events
ArQule management to meet with SVB Leerink »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

DB

Deutsche Bank

$9.26

0.375 (4.22%)

06:19
03/19/19
03/19
06:19
03/19/19
06:19
Periodicals
Deutsche Bank loaned over $2B to Trump over two decades, NYT reports »

Before becoming U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFMD

Affimed N.V.

$3.92

-0.08 (-2.00%)

, RHHBY

Roche

$0.00

(0.00%)

06:18
03/19/19
03/19
06:18
03/19/19
06:18
Hot Stocks
Affimed to receive milestone payment under collaboration with Genentech »

Affimed (AFMD) announced…

AFMD

Affimed N.V.

$3.92

-0.08 (-2.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

WTR

Aqua America

$35.97

0.02 (0.06%)

06:18
03/19/19
03/19
06:18
03/19/19
06:18
Upgrade
Aqua America rating change  »

Aqua America upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

06:18
03/19/19
03/19
06:18
03/19/19
06:18
Conference/Events
Amazon.com management to meet with Wolfe Research »

Wolfe Research Senior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

GOOG

Alphabet

$1,183.66

-1.6 (-0.13%)

, GOOGL

Alphabet Class A

$1,188.09

-3.69 (-0.31%)

06:17
03/19/19
03/19
06:17
03/19/19
06:17
Periodicals
YouTube had AI block Christchurch massacre videos, Washington Post reports »

YouTube says videos of…

GOOG

Alphabet

$1,183.66

-1.6 (-0.13%)

GOOGL

Alphabet Class A

$1,188.09

-3.69 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

TLRY

Tilray

$72.15

-0.38 (-0.52%)

06:16
03/19/19
03/19
06:16
03/19/19
06:16
Recommendations
Tilray analyst commentary  »

Piper maintains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$76.93

-0.07 (-0.09%)

06:16
03/19/19
03/19
06:16
03/19/19
06:16
Hot Stocks
Baxter, bioMerieux announce collaboration to improve treatment of AKI »

Baxter and bioMerieux…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TSLA

Tesla

$269.46

-5.97 (-2.17%)

06:16
03/19/19
03/19
06:16
03/19/19
06:16
Periodicals
SEC calls Tesla CEO tweet 'a blatant violation' of settlement deal, CNBC says »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

AKTS

Akoustis

$6.47

-0.02 (-0.31%)

06:15
03/19/19
03/19
06:15
03/19/19
06:15
Conference/Events
Akoustis management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

ACER

Acer Therapeutics

$23.30

0.03 (0.13%)

06:14
03/19/19
03/19
06:14
03/19/19
06:14
Conference/Events
Acer Therapeutics management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 04

    Apr

  • 25

    Jun

VEDL

Vedanta

$10.08

0.02 (0.20%)

06:13
03/19/19
03/19
06:13
03/19/19
06:13
Hot Stocks
Vedanta reports violent protest in Lanjigarh plant »

Yesterday morning some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$0.00

(0.00%)

, GRUB

GrubHub

$77.03

2.05 (2.73%)

06:13
03/19/19
03/19
06:13
03/19/19
06:13
Periodicals
Bankers to compare Lyft to Grubhub, Farfetch ahead of IPO, BI reports »

Bankers will compare Lyft…

LYFT

Lyft

$0.00

(0.00%)

GRUB

GrubHub

$77.03

2.05 (2.73%)

FTCH

Farfetch

$27.15

0.08 (0.30%)

SQ

Square

$75.20

-1.43 (-1.87%)

FB

Facebook

$160.46

-5.53 (-3.33%)

NFLX

Netflix

$363.27

1.64 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 27

    Mar

  • 04

    Apr

  • 28

    May

  • 29

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.